{
    "organizations": [],
    "uuid": "26fd7359eebb5af78801badb27eeb873cef94600",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-bb-biotech-q1-profit-of-chf-28-mln/brief-bb-biotech-q1-profit-of-chf-28-mln-idUSASO0003LA",
    "ord_in_thread": 0,
    "title": "BRIEF-BB Biotech Q1 Profit Of CHF 28 Mln",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 20 (Reuters) - BB Biotech AG:\n* DGAP-ADHOC: BB BIOTECH SHARE GAINS VALUE IN FIRST QUARTER 2018 - SEVERAL LARGE-CAP BIOTECH COMPANIES TRADING AT WELL BELOW FUNDAMENTAL VALUE\n* Q1 PROFIT OF CHF 28 MN (CHF 375 MN IN CORRESPONDING PERIOD OF PREVIOUS YEAR) Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-20T13:04:00.000+03:00",
    "crawled": "2018-04-21T18:23:23.002+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "bb",
        "biotech",
        "ag",
        "bb",
        "biotech",
        "share",
        "gain",
        "value",
        "first",
        "quarter",
        "several",
        "biotech",
        "company",
        "trading",
        "well",
        "fundamental",
        "value",
        "q1",
        "profit",
        "chf",
        "mn",
        "chf",
        "mn",
        "corresponding",
        "period",
        "previous",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}